Francesc Mitjans

1.5k citations
32 papers · 1.3k indexed · h-index 18

Impact in

Papers in

Francesc Mitjans

31 papers receiving 1.3k citations

Peers

Francesc Mitjans
Comparison fields: 5 of 79
  • Immunology and Allergy 609
  • Cancer Research 250
  • Oncology 345
  • Molecular Biology 764
  • Immunology 233
Replace Dirk Wienke with:
Dirk Wienke United Kingdom
Graeme J. Dougherty United States
Jennifer R. Allport United States
Daniel Rajotte United States
Shashi Uniyal Canada
Darwin Asa United States
Roger Briesewitz United States
Grit Zahn Germany
Daniel Lietha Spain
Karna Skorstengaard Denmark
Francesc Mitjans relative to Dirk Wienke United Kingdom Dirk Wienke's profile →
Citations per field
00.5×1.5×2.4×
Dirk Wienke · 1×
Citations per year

Countries citing papers authored by Francesc Mitjans

Since Specialization
Citations

This map shows the geographic impact of Francesc Mitjans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesc Mitjans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesc Mitjans more than expected).

Fields of papers citing papers by Francesc Mitjans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesc Mitjans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesc Mitjans. The network helps show where Francesc Mitjans may publish in the future.

Co-authors

The 25 scholars most cited alongside Francesc Mitjans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Francesc Mitjans Line = papers co-authored together Francesc Mitjans links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20232
2 201814
3 201814
4 201738
5 201451
6 20132
7 201317
8 201383
9 201112
10 201020
11 200623
12 200558
13 200456
14 200428
15 200238
16 200112
17 200177
18 2000127
19 200025
20
In vivo therapy of malignant melanoma by means of antagonists of alphav integrins.
2000148

About Francesc Mitjans

Francesc Mitjans is a scholar working on Immunology and Allergy, Toxicology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Molecular Biology, having authored 32 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (18 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Chemical Synthesis and Analysis (5 papers), Protease and Inhibitor Mechanisms (5 papers), Angiogenesis and VEGF in Cancer (4 papers), S100 Proteins and Annexins (4 papers), Click Chemistry and Applications (3 papers) and Photonic and Optical Devices (3 papers). The work is most often cited by research in Immunology and Allergy (609 citations), Cancer Research (250 citations), Oncology (345 citations), Molecular Biology (764 citations) and Immunology (233 citations). Francesc Mitjans has collaborated with scholars based in Spain, Germany and United Kingdom. Frequent co-authors include Jaume Piulats, Simon L. Goodman, John F. Marshall, Alfred Jonczyk, Claus Fittschen, Germán Reyes, Tim Meyer, Jaume Adán, Éric Petitclerc and David A. Cheresh. Their work appears in journals such as Bioconjugate Chemistry, Journal of Cell Science, International Journal of Cancer, Oncogene and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026